Intragastrical administration of genistein (4 and 8 mg/kg/day) for 12 weeks significantly and dose-dependently inhibited HFD induced up-regulation of TNF-α and IL-6 levels, and their mRNA expression in serum and liver of NASH rats. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.